SOCIETY ON SARCOPENIA, CACHEXIA, & WASTING DISORDERS (SCWD)
The Leading International Conference on Cachexia, Sarcopenia & Muscle Wasting
Join clinicians, researchers and experts advancing the science of muscle wasting disorders. Over 400 clinicians and researchers from 45+ countries attend SCWD each year
- 📍 Washington, DC •
- December 10–12, 2026
From Basic Science to Clinical Management of Sarcopenia, Cachexia and Wasting
Multidisciplinary Approaches to Improve Patients’ Outcomes
The Society on Sarcopenia, Cachexia, and Wasting Disorders (SCWD) focuses on muscle wasting across a number of medical conditions and strives to enhance global health by advancing cutting-edge research that informs effective policies and practices for medical professionals and healthcare stakeholders.
Our mission is to address the challenges of cachexia (including cancer cachexia), sarcopenia, and wasting disorders involving all stakeholders to improve the lives of patients with cachexia and sarcopenia worldwide.
Explore the latest programs and information about Sarcopenia, Cachexia, & Wasting Disorders
Stay Involved
SCIENCE & RESEARCH
Your Area of Expertise
Explore our Programs and Resources
- 🗓️ Date: 2026-08-22
- 📰 Journal: Journal Of Cachexia Sarcopenia And Muscle
- 🗓️ Date: 2026-08-22
- 📰 Journal: Journal Of Cachexia Sarcopenia And Muscle
- 🗓️ Date: 2026-08-20
- 📰 Journal: Molecular Therapy
- 🗓️ Date: 2026-08-18
- 📰 Journal: Chinese Medical Journal
- 🗓️ Date: 2026-08-18
- 📰 Journal: Journal Of Cachexia Sarcopenia And Muscle
- 🗓️ Date: 2026-08-14
- 📰 Journal: Journal Of Cachexia Sarcopenia And Muscle
- 🗓️ Date: 2026-08-13
- 📰 Journal: Experimental Physiology
- 🗓️ Date: 2026-08-10
- 📰 Journal: Journal Of Cachexia Sarcopenia And Muscle
- 🗓️ Date: 2026-08-09
- 📰 Journal: Ageing Research Reviews
Do muscle strength cut-offs used to define sarcopenia affect trajectories of disability progression in basic activities of daily living in older adults?
Correction to 'A Prospective Observational Study of Anamorelin During Chemoimmunotherapy in Non-Small Cell Lung Cancer With Cachexia (SPIRAL-ANA)'.
Adenosine monophosphate-activated protein kinase: A golden mediator of exercise in metabolic dysfunction-associated diseases (review).
Body Composition in Heart Failure: A Magnetic Resonance Imaging and Dual X-Ray Absorptiometry Assessment in the UK Biobank Study.
Preoperative swallowing muscle mass is associated with 1-year skeletal muscle loss and subsequent survival in lung cancer.
Our Dedication to Advancing Science
The Journal of Cachexia, Sarcopenia and Muscle is committed to pioneering research that addresses the critical challenges of cachexia and sarcopenia. By publishing the finest work from across the life sciences, we unite experts to push the boundaries of knowledge and improve patient care. Discover how our journal can support your research through opportunities for publication and collaboration.
Register Now!
Embrace this opportunity to redefine the field and create lasting impact in the lives of patients worldwide.
